Caffeine and Progression of Parkinson Disease. Issue 5 (September 2015)
- Record Type:
- Journal Article
- Title:
- Caffeine and Progression of Parkinson Disease. Issue 5 (September 2015)
- Main Title:
- Caffeine and Progression of Parkinson Disease
- Authors:
- Simon, David K.
Wu, Cai
Tilley, Barbara C.
Wills, Anne-Marie
Aminoff, Michael J.
Bainbridge, Jacquelyn
Hauser, Robert A.
Schneider, Jay S.
Sharma, Saloni
Singer, Carlos
Tanner, Caroline M.
Truong, Daniel
Wong, Pei Shieen - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p>Increased caffeine intake is associated with a lower risk of Parkinson disease (PD) and is neuroprotective in mouse models of PD. However, in a previous study, an exploratory analysis suggested that, in patients taking creatine, caffeine intake was associated with a faster rate of progression. In the current study, we investigated the association of caffeine with the rate of progression of PD and the interaction of this association with creatine intake.</p> </sec> <sec> <title>Methods</title> <p>Data were analyzed from a large phase 3 placebo-controlled clinical study of creatine as a potentially disease-modifying agent in PD. Subjects were recruited for this study from 45 movement disorders centers across the United States and Canada. A total of 1741 subjects with PD participated in the primary clinical study, and caffeine intake data were available for 1549 of these subjects. The association of caffeine intake with rate of progression of PD as measured by the change in the total Unified Parkinson Disease Rating Scale score and the interaction of this association with creatine intake were assessed.</p> </sec> <sec> <title>Results</title> <p>Caffeine intake was not associated with the rate of progression of PD in the main analysis, but higher caffeine intake was associated with significantly faster progression among subjects taking creatine.</p> </sec> <sec><abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective</title> <p>Increased caffeine intake is associated with a lower risk of Parkinson disease (PD) and is neuroprotective in mouse models of PD. However, in a previous study, an exploratory analysis suggested that, in patients taking creatine, caffeine intake was associated with a faster rate of progression. In the current study, we investigated the association of caffeine with the rate of progression of PD and the interaction of this association with creatine intake.</p> </sec> <sec> <title>Methods</title> <p>Data were analyzed from a large phase 3 placebo-controlled clinical study of creatine as a potentially disease-modifying agent in PD. Subjects were recruited for this study from 45 movement disorders centers across the United States and Canada. A total of 1741 subjects with PD participated in the primary clinical study, and caffeine intake data were available for 1549 of these subjects. The association of caffeine intake with rate of progression of PD as measured by the change in the total Unified Parkinson Disease Rating Scale score and the interaction of this association with creatine intake were assessed.</p> </sec> <sec> <title>Results</title> <p>Caffeine intake was not associated with the rate of progression of PD in the main analysis, but higher caffeine intake was associated with significantly faster progression among subjects taking creatine.</p> </sec> <sec> <title>Conclusions</title> <p>This is the largest and longest study conducted to date that addresses the association of caffeine with the rate of progression of PD. These data indicate a potentially deleterious interaction between caffeine and creatine with respect to the rate of progression of PD.</p> </sec> </abstract> … (more)
- Is Part Of:
- Clinical neuropharmacology. Volume 38:Issue 5(2015)
- Journal:
- Clinical neuropharmacology
- Issue:
- Volume 38:Issue 5(2015)
- Issue Display:
- Volume 38, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 38
- Issue:
- 5
- Issue Sort Value:
- 2015-0038-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-09
- Subjects:
- Neuropharmacology -- Periodicals
615.78 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00002826-000000000-00000 ↗
http://journals.lww.com/clinicalneuropharm/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/WNF.0000000000000102 ↗
- Languages:
- English
- ISSNs:
- 0362-5664
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.310600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3500.xml